Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Vangeel L, Chiu W, De Jonghe S, Maes P, et al. Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern. Antiviral Res 2022 Jan 24:105252. doi: 10.1016/j.antiviral.2022.105252.
PMID: 35085683


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016